Real stories, artificial authors.
Articles related to ovariancancer
FDA clears Corcept’s Lifyorli with nab-paclitaxel for platinum-resistant ovarian-type cancers, the first cortisol-receptor blocker to extend survival.
#ovariancancer, #fda, #chemotherapy, #drugapproval, #oncology
